Le marché des aiguilles cardiovasculaires était évalué à 84,429 millions de dollars US en 2021 et devrait atteindre 137,855 millions de dollars US d'ici 2028 ; il devrait croître à un TCAC de 7,3 % de 2021 à 2028.
Les aiguilles cardiovasculaires sont utilisées lors de chirurgies à cur ouvert, de procédures de valves cardiaques, de procédures de transplantation cardiaque, de pontages aortocoronariens, etc. sur. Ces aiguilles sont de deux types : les aiguilles à usage unique ou sans chas et les aiguilles à usage multiple ou à chas. Les aiguilles cardiovasculaires sont fabriquées à partir de nouveaux alliages d'acier inoxydable à forte concentration de nickel, de Surgalloy et d'Ethalloy.
Le marché des aiguilles cardiovasculaires a été segmenté en fonction du type, de l'application, de l'utilisation, de l'utilisateur final et de la géographie. Le marché, par géographie, est principalement segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale. Le rapport offre des informations et une analyse approfondie du marché des aiguilles cardiovasculaires, en mettant l'accent sur des paramètres tels que les tendances du marché, les progrès technologiques et la dynamique du marché, ainsi qu'une analyse du paysage concurrentiel des principaux acteurs du marché mondial.
Régions lucratives pour le marché des aiguilles cardiovasculaires
Aperçus du marchéL'augmentation de la prévalence des maladies cardiovasculaires stimule la croissance du marché des aiguilles cardiovasculaires
Les maladies cardiovasculaires (MCV) sont les troubles du cur et des vaisseaux sanguins, et la catégorie comprend les maladies cérébrovasculaires, les maladies coronariennes, les cardiopathies rhumatismales et d'autres affections. La consommation de tabac, une mauvaise alimentation et l'inactivité physique, qui augmentent le risque de crises cardiaques et d'accidents vasculaires cérébraux, sont quelques-uns des principaux facteurs liés au mode de vie qui conduisent aux maladies cardiovasculaires. D'autres facteurs de risque à l'origine de ces maladies comprennent l'hypertension, le diabète et l'augmentation du taux de cholestérol. Les maladies cardiovasculaires font partie des 10 principales causes de décès dans le monde. Selon l'Organisation mondiale de la santé (OMS), les maladies cardiovasculaires sont la première cause de décès dans le monde. Les maladies cardiovasculaires (MCV) resteront probablement la principale cause de morbidité et de mortalité dans le monde. Selon les données de l'OMS, environ 17,9 millions de personnes dans le monde sont décédées des suites de maladies cardiovasculaires en 2016, soit 31,0 % de la mortalité totale signalée cette année-là. Parmi ceux-ci, environ 85% des décès étaient dus à une crise cardiaque et à un accident vasculaire cérébral. Les dépôts de graisse autour des vaisseaux sanguins qui empêchent le sang de circuler vers le cur ou le cerveau sont l'une des principales causes de crise cardiaque et d'accident vasculaire cérébral. Les vaisseaux sanguins ou les caillots sanguins dans le cerveau sont quelques autres causes d'accident vasculaire cérébral.
Selon les statistiques européennes sur les maladies cardiovasculaires 2017, les maladies cardiovasculaires causent 3,9 millions et plus de 1,8 million de décès en Europe et dans l'Union européenne (UE) , respectivement, chaque année. Ainsi, ces maladies représentent respectivement 45,0 % et 37,0 % de la mortalité totale en Europe et dans l'UE. De plus, selon les statistiques 2019 de l'American Heart Association (AHA), 121,5 millions d'adultes aux États-Unis, soit environ 50 % de la population adulte américaine, souffrent de maladies cardiovasculaires chaque année. Selon le Journal de l'American College of Cardiology, l'Asie a une prévalence de plus en plus élevée d'hypertension artérielle, de diabète et de taux de cholestérol élevés. Des pays comme le Japon, la Chine et l'Inde sont les principaux contributeurs à l'incidence totale des maladies cardiovasculaires dans la région. Ainsi, l'augmentation significative de l'incidence des maladies cardiovasculaires à travers le monde contribue à la forte demande de dispositifs cardiovasculaires de diagnostic et de traitement, qui stimule la croissance du marché des aiguilles cardiovasculaires.
Aperçus basés sur le type
Selon le type, le marché des aiguilles cardiovasculaires est segmenté en aiguilles à corps rond et aiguilles coupantes. Le segment des aiguilles à corps rond représenterait une plus grande part de marché en 2021, et le segment des aiguilles coupantes devrait enregistrer un TCAC plus élevé sur le marché au cours de la période de prévision.
Marché des aiguilles cardiovasculaires, par type - 2021 ET 2028
Insights basés sur les applications
Basé sur les applications, le marché des aiguilles cardiovasculaires est segmenté en chirurgie à cur ouvert et en procédures valvulaires cardiaques. Le segment de la chirurgie à cur ouvert devrait détenir une plus grande part du marché en 2021, et on estime qu'il enregistrera un TCAC plus élevé sur le marché au cours de la période 2021-2028. La croissance du segment de la chirurgie à cur ouvert est attribuée à l'augmentation des chirurgies à cur ouvert dans le monde.
Couverture des rapports
Insights basés sur l'utilisation
Basé sur utilisation, le marché des aiguilles cardiovasculaires est segmenté en usage unique et usage multiple. On estime que le segment à usage unique représentera une plus grande part de marché en 2021. Le marché de ce segment devrait croître à un TCAC plus élevé de 2021 à 2028.
Informations basées sur l'utilisateur final
En fonction de l'utilisateur final, le marché des aiguilles cardiovasculaires est segmenté en hôpitaux et cliniques, centres de chirurgie ambulatoire et centres cardiovasculaires. Le segment des hôpitaux et cliniques détiendrait la plus grande part du marché en 2021 ; on estime en outre qu'il enregistrera le TCAC le plus élevé du marché au cours de la période de prévision.
La pandémie de COVID-19 est devenue le défi le plus important à travers le monde. Comme cette pandémie a mis à rude épreuve les systèmes de santé du monde entier, il était essentiel de donner la priorité aux ressources limitées pour minimiser les admissions à l'hôpital. Les patients en chirurgie cardiaque nécessitent non seulement des ressources vitales en soins intensifs, mais sont également potentiellement dans la catégorie de complications la plus à risque de COVID-19. Par conséquent, la plupart des hôpitaux et des chirurgiens ont envisagé d'annuler ou de reporter les chirurgies électives, y compris les chirurgies cardiovasculaires. Par conséquent, l'impact du COVID 19 devrait être quelque peu négatif sur le marché des aiguilles cardiovasculaires à court terme. Cependant, à long terme, à mesure que le calendrier de vaccination s'établira et que le taux de transmission diminuera, les systèmes de santé reviendront à la normale et auront une demande accrue d'aiguilles cardiovasculaires, ce qui soutiendra le marché.
Acquisitions, collaborations, partenariats , les lancements de produits et les extensions sont des stratégies couramment adoptées par les entreprises pour étendre leur présence dans le monde entier et répondre à la demande croissante. Les acteurs du marché des aiguilles cardiovasculaires ont principalement adopté la stratégie d'innovation de produits pour répondre à l'évolution de la demande des clients à travers le monde, ce qui les aide également à maintenir leur marque à l'échelle mondiale.
Profils des entreprises
- Ethicon (Johnson & Johnson Services, Inc.)
- Mani, Inc
- Barber of Sheffield
- FSSB chirurgicale needles GmbH
- Aurolab
- Teleflex Incorporated
- Meril Life Sciences Pvt.
- CP Medical
- SMB Corporation of India
< li>Medtronic
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Cardiovascular Needle market majorly consists of the players such as players Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB surgical needles GmbH, Medtronic, Aurolab., Teleflex Incorporated., Meril Life Sciences Pvt. Ltd., CP Medical., SMB Corporation of India and among others.
The factors that are restraining the adoption of cardiovascular needle are increasing use of surgical staples instead of needles and suture.
The factors that are driving growth of the market are increase in prevalence of cardiovascular diseases across the world and rising geriatric population. There are also other factors that fuel the growth of the market such as excessive intake of tobacco, high number of smoking population, obesity, increasing co-morbidities, and changing standard of living.
The cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. These cardiovascular needles are of two types: single use or eyeless needles and multiple use or eyed needles. Cardiovascular needles are manufactured from new stainless-steel alloys containing high concentrations of nickel, Surgalloy and Ethalloy.
The List of Companies - Cardiovascular Needle Market
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Aurolab
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)